Treatment strategies for gastric cancer during the COVID-19 pandemic

Kang, Wenzhe; Zhong, Yuxin; Ma, Fuhai; Líu, Hao; Ma, Shuai; Yang, Li; Hu, Haitao; Li, Weikun; Tian, Yantao

doi:10.12998/wjcc.v8.i21.5099

Cited by 7 publications

(7 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Regarding patient prognosis, studies in the literature indicate a slight increase in postoperative mortality rate, although not statistically significant [ 29 ]. The delay of surgical treatment by 2, 4, 6, or 8 weeks does not impact patient prognosis, particularly in stages I or II [ 9 , 13 , 16 , 28 , 30 ].…”

Section: Discussionmentioning

confidence: 99%

The Challenges of Gastric Cancer Surgery during the COVID-19 Pandemic

Feier,

Faur,

Muntean

et al. 2023

Healthcare

View full text Add to dashboard Cite

. The aim of this study was to quantify the impact of the COVID-19 pandemic on the surgical treatment of patients with gastric cancer. Data from patients undergoing surgery for gastric cancer during the pandemic were analyzed and the results obtained were compared with the corresponding periods of 2016–2017 and 2018–2019. Various parameters were taken into consideration and their dynamics highlight significant changes in the pandemic year compared with the two pre-pandemic periods. Statistical analysis revealed a marked decrease in the number of surgeries performed during the pandemic (p < 0.001). Severe prognostic factors for gastric cancer, including weight loss and upper gastrointestinal hemorrhage, were associated with an increased number of postoperative fistulas, while emesis was statistically correlated with a more advanced cancer stage (p < 0.011). There was also a reduction in the total duration of hospitalization (p = 0.044) and postoperative hospitalization (p = 0.047); moreover, the mean duration of surgical intervention was higher during the pandemic (p = 0.044). These findings provide evidence for the significant changes in clinical and therapeutic strategies applied to patients undergoing surgery for gastric cancer during the study period. The ongoing pandemic has exerted a substantial and complex impact, the full extent of which remains yet to be fully comprehended.

show abstract

Section: Discussionmentioning

confidence: 99%

The Challenges of Gastric Cancer Surgery during the COVID-19 Pandemic

Feier,

Faur,

Muntean

et al. 2023

Healthcare

View full text Add to dashboard Cite

show abstract

“…The Eastern literature indicates that the time to gastric cancer progression is approximately 36-44 months [6]. For most patients, a wait time of a few months does not have a significant impact on the prognosis [7]. Our study observed that the nonneoadjuvant CT group had a similar time to surgery in the pre-COVID-19 and during COVID-19 periods, which was approximately 3 months.…”

Section: Discussionmentioning

confidence: 47%

The effect of Covid-19 pandemic on gastric cancer surgery

İflazoğlu¹,

Yalkın²

2021

Journal of Surgery and Medicine

View full text Add to dashboard Cite

Background/Aim: The global spread of the COVID-19 pandemic has led to difficulties in the prevention of other diseases and especially in the maintenance of cancer treatment, along with the attempts to control the pandemic. The present study aims to investigate the clinical, oncological, and financial effects of COVID-19 on patients undergoing radical gastric cancer surgery. Methods: This retrospective cohort study included 46 patients and the clinical, epidemiological, radiological, and laboratory data of these patients were analyzed. Inclusion criteria were patients who were diagnosed with gastric cancer, who underwent radical surgical resection in pre-COVID-19 and during COVID-19 periods. Appropriate surgical options were used by taking precautions against viral transmission. Results: Of the study patients, 56.5% were males, the median age was 69 (42-83) years, and the median length of stay was 9 (7-34) days. The rate of thoracic computed tomography (CT) taken was statistically significantly higher in during-COVID-19 period (P=0.008). The length of the surgery was statistically significantly longer and the estimated blood loss (cc) was lower in during-COVID-19 period (P<0.001, P=0.043, respectively). From a financial point of view, the cost was statistically significantly higher during-COVID-19 period (P=0.038). Conclusion:The use of thoracic CT in the surgical management of gastric cancer patients was increased, the surgery was prolonged, and the estimated blood loss was reduced along with the pandemic. In addition, the cost of patient treatment increased due to increasing amount of the routine examination and surgical materials used.

show abstract

“…Evaluation of undernourished patients ate is understood by digestive support, to a degree spoken digestive supplements, which are the best choice alternative. 79 …”

Section: Nutritional Care In Patients With Gastric Cancermentioning

confidence: 99%

The Effect of Coronavirus Disease 2019 on the Quality of Associated Care in Patients with Gastric Cancer

Omidifar,

Pazoki,

Shokripour

et al. 2024

Middle East J Dig Dis

View full text Add to dashboard Cite

Coronavirus is a new virus that has affected human life on a large scale; it has infected millions of people and killed hundreds of thousands of people. In contrast, among cancers, stomach neoplasia is the most common cancer of the upper gastrointestinal (UGI) tract. COVID-19 disease has disrupted the optimal management of patients with cancer. Metastasis, deterioration of the patient’s nutritional status, UGI bleeding, and increased surgical complications are all consequences of delayed treatment of patients with gastric cancer. However, there is still insufficient evidence on the immunogenicity of the vaccine and the protection provided by coronavirus vaccines in patients with cancer, especially those with immunodeficiency or those who are treated for certain types of cancers. Also, as part of the prevention and control of COVID-19 disease, nutritional support for patients with gastrointestinal cancer is particularly important, and the psychological and physiological limitations caused by the disease duration are hurting the well-being of patients. Therefore, the assessment of the impact of the coronavirus on cancer should be treated as an important issue, and healthcare professionals should be prepared to deal with the long-term effects of the coronavirus disease.

show abstract

Treatment strategies for gastric cancer during the COVID-19 pandemic

Cited by 7 publications

References 16 publications

The Challenges of Gastric Cancer Surgery during the COVID-19 Pandemic

The Challenges of Gastric Cancer Surgery during the COVID-19 Pandemic

The effect of Covid-19 pandemic on gastric cancer surgery

The Effect of Coronavirus Disease 2019 on the Quality of Associated Care in Patients with Gastric Cancer

Contact Info

Product

Resources

About